Responses
Oncolytic and local immunotherapy
Original research
In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models
Compose a Response to This Article
Other responses
No responses have been published for this article.
